Evidence map›Paper›PMID 26301171›Full record

ArticleCurrent addiction reports2015

Nicotinic receptor contributions to smoking: insights from human studies and animal models.

Darlene H Brunzell, Alexandra M Stafford, Claire I Dixon

Open access · bronzeAbstract read
In one paragraph

Article in Current addiction reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. CHRNA5-A3-B4, CYP2A6, and DBH Genetic Associations With Smoking Cessation Throughout Adulthood Within Two Longitudinal Studies of Women.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Association of PolymorphismInternational journal of environmental research and public health · 2022
    Article
  10. Dynamic activity of interpeduncular nucleus GABAergic neurons controls expression of nicotine withdrawal in male mice.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Article
  11. Review
  12. Article
  13. Review
  14. Rodent models for nicotine withdrawal.Journal of psychopharmacology (Oxford, England) · 2021
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Profound alteration in reward processing due to a human polymorphism in CHRNA5: a role in alcohol dependence and feeding behavior.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Darlene H BrunzellDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA.
Alexandra M StaffordDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA.
Claire I DixonDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA.
Virginia Commonwealth University · US

Funding

Project 5 - Genetic architecture of alcohol use disorder using cross-trait genetic correlations and public next-generation sequencing studiesP50AA022537 · NIAAA · VIRGINIA COMMONWEALTH UNIVERSITY · PI MICHAEL F MILES · 2014 to 2026
$19.6M
TRAINING IN THE PHARMACOLOGY OF ABUSED DRUGST32DA007027 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI William L. Dewey · 1985 to 2026
$14.7M
VCU Center for Drug Addiction ResearchP30DA033934 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI JOLENE J WINDLE · 2014 to 2026
$13.8M
Nicotinic contributions to affective behaviorR01DA031289 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI BRUNZELL, DARLENE H · 2011 to 2015
$1.6M
Medication development of a novel therapeutic for smoking cessationUH3TR000958 · NCATS · VIRGINIA COMMONWEALTH UNIVERSITY · PI BRUNZELL, DARLENE H, PERKINS, KENNETH ALAN · 2014 to 2015
$1.6M
Novel bivalent multifunctional ligands towards Alzheimer's diseaseR01AG041161 · NIA · VIRGINIA COMMONWEALTH UNIVERSITY · PI ZHANG, SHIJUN · 2012 to 2016
$1.5M
Medication development of a novel therapeutic for smoking cessationUH2TR000958 · NCATS · VIRGINIA COMMONWEALTH UNIVERSITY · PI BRUNZELL, DARLENE H, PERKINS, KENNETH ALAN · 2013 to 2013
$482k
NCATS NIH HHS UH2 TR000958NCATS NIH HHS UH3 TR000958NIAAA NIH HHS P50 AA022537NIA NIH HHS R01 AG041161NIDA NIH HHS P30 DA033934NIDA NIH HHS R01 DA031289NIDA NIH HHS T32 DA007027
6 · The paper itself

Abstract

It is becoming increasingly evident that a variety of factors contribute to smoking behavior. Nicotine is a constituent of tobacco smoke that exerts its psychoactive effects via binding to nicotinic acetylcholine receptors (nAChRs) in brain. Human genetic studies have identified polymorphisms in nAChR genes, which predict vulnerability to risk for tobacco dependence.

Indexed as

acetylcholineaddictioncholinergice-cigarettesnicotinetobacco

Identifiers

PMID26301171
PMCPMC4540370
OpenAlexW1996324545

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.